Founded in 1978, Biogen is a leading biotechnology company that pioneers innovative science to deliver new medicines to transform patients’ lives and to create value for shareholders and our communities. We apply deep understanding of human biology and leverage different modalities to advance first-in-class treatments or therapies that deliver superior outcomes. Our approach is to take bold risks, balanced with return on investment to deliver long-term growth.
Company
About Biogen
Science & Innovation
R&D Expertise
Our deep scientific expertise and our courage to take risks make us leaders in the research and development of medicines.
Medicines
Our medicines aim to improve the well-being of people around the world.
Manufacturing
Our technology and engineering capabilities help bring our high-quality medicines to market.
Our U.S. Legacy
Headquartered in Cambridge, Massachusetts, Biogen is one of the oldest independent American biotechnology companies.
100%
of clinical trials initiated in 2022 included a plan to recruit underrepresented patients
80+
countries in which our therapies are available
40
countries served by our Expanded Access Program
Caring Deeply. Achieving Excellence. Changing Lives.
Our culture unites the people of Biogen within a spirit of ethics, inclusivity, agility and unwavering patient focus.
Meet our leaders
President and Chief Executive Officer
Christopher A. Viehbacher
Chief Legal Officer
Susan H. Alexander
Chief Human Resources Officer
Ginger Gregory, Ph.D.
Head of Global Product Strategy & Commercialization
Rachid Izzar
Head of Pharmaceutical Operations and Technology
Nicole Murphy
See all our leaders
